Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Real Madrid begins contacts with Martín Zubimendi’s alternative in the center of the field for 60 million euros

Real Madrid have decided that, after the retirement of Toni Kroos left them a little lost in the center of the field, they will reinforce that area of ​​​​the field next summer. His priority is Martín Zubimendi.

The Real Sociedad star will be available for €60 million, but he must be convinced to make a move and he must beat the competition. Thus, Diario AS explains that Atalanta midfielder Ederson dos Santos has been identified as a possible alternative.

His performance against the whites in the Champions League impressed in December. A new arrival could see Aurelien Tchouameni leave the club, with Ederson also available for around €60m. Atlético Madrid and Barcelona have looked at Ederson in the past, with Atlético having a €55m bid rejected last summer before signing for Conor Gallagher. However, the Madrid newspaper claims that Atalanta will facilitate the exit, since Teun Koopmeiner’s departure to Juventus rules out the possibility of Ederson moving.

The 25-year-old hasn’t batted an eyelid as Atalanta have gone on an excellent run, with the Brazilian at the heart of their current Scudetto title, and aiming to qualify for the top eight of the Champions League. Ederson also recently made his debut for Brazil.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.